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Introduction
Formaldehyde is a widely used chemical, with global production of over 20 million tons per
year (International Agency for Research on Cancer, 2012). It is utilized in industrial and
consumer products and is also produced as a byproduct of fires, cigarette smoke and
automotive exhaust. Furthermore, it is released from products used in building materials
such as particle board and carpet. It has long been used as a fixation product for pathology
specimens and in embalming. However, what is often not realized is that formaldehyde is
also one of the oldest chemicals in the world. Life started with one carbon chemistry and
formaldehyde was one of the earliest chemicals formed and utilized in cells. There are
numerous sources of endogenous formaldehyde, including the one carbon pool, amino acid
metabolism, methanol metabolism, lipid peroxidation, and p450 dependent demethylation
(O-, N-, and S-methyl).
In 1980, formaldehyde was shown to be a carcinogen of the nasal passages of rats exposed
by inhalation (Swenberg et al., 1980). This finding was followed by an intense effort to
understand the Mode of Action (MOA). More than thirty years of research has focused on
confirmation of its carcinogenicity, MOA studies and vastly expanded epidemiologic
studies. This paper will briefly cover salient features of these comprehensive studies to place
the carcinogenicity, epidemiology and risks of formaldehyde in perspective.
Carcinogenicity Studies
Part of the mission of the newly formed Chemical Industry Institute of Toxicology (CIIT)
was to conduct state-of-the-art toxicity and carcinogenicity bioassays on commodity
chemicals. In 1978, a 2-year carcinogenicity study in F344 rats and B6C3F1 mice exposed
by inhalation to 0, 2, 5.6 or 14.3 ppm formaldehyde was initiated at Battelle, Columbus. The
12-month interim report noted that two rats in the high exposure group had squamous cell
carcinomas of the nasal passages. In the 13th month of the study, a third squamous cell
carcinoma was diagnosed in a rat from the same treatment group. This was alarming, as
nasal squamous cell carcinomas are very rare neoplasms in rats. The FDA, CPSC, EPA and
CIIT sponsors were simultaneously alerted to a strong concern that formaldehyde was likely
to be carcinogenic. The first report on formaldehyde's carcinogenicity in the peer-reviewed
literature appeared in September, 1980 (Swenberg et al., 1980). At 18 months into the study,
36 rats exposed to 14.3 ppm formaldehyde had developed squamous cell carcinomas, but no
nasal cancers were present in rats exposed to 2 or 5.6 ppm, or in mice exposed to 2, 5.6 or
14.3 ppm formaldehyde. This report was followed by a comprehensive publication of the
Battelle study by William Kerns, the study pathologist (Kerns et al., 1983). The exposures
for this study were conducted for up to 24 months (6 hrs/day, 5 days/week) for male and
female rats and mice. Additional animals were held up to 6 months post exposure to follow
progression and/or regression of lesions. Significant formaldehyde-induced lesions were
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confined to the nasal tissues and proximal trachea. The distribution and severity of the
pathology were concentration-dependent. Rhinitis, squamous metaplasia and epithelial
dysplasia were diagnosed in all formaldehyde-exposed groups of rats and in the 5.6 and 14.3
ppm groups of mice. With increasing post-exposure time, these non-malignant lesions
regressed. In total, 103 rats and 2 mice exposed to 14.3 ppm formaldehyde developed
squamous cell carcinomas of the nose, as did two rats exposed to 5.6 ppm.
The initial carcinogenicity study was followed by a second inhalation study with F344 rats
that incorporated two additional formaldehyde exposure concentrations, 0.7 and 10 ppm, as
well as the original 0, 2, 6 and 15 ppm exposures (Monticello et al., 1990; Monticello et al.,
1996). This study contained detailed evaluations of cell proliferation at 6, 12, and 18 months
of exposure. Figure 1 illustrates the exposure-response relationships for squamous cell
carcinoma in the Kerns' and Monticello studies, as well as the exposure and time
relationships for cell proliferation. It clearly demonstrates the persistent and strong
concentration-dependent increases in cell proliferation that are key events in the Mode of
Action (MOA) for formaldehyde carcinogenesis.
The findings of the CIIT inhalation studies have been confirmed by several other
laboratories (International Agency for Research on Cancer, 2006). In addition, several oral
studies were conducted that were also reviewed by IARC.
Epidemiology of Formaldehyde and Cancer
The epidemiology of formaldehyde-induced cancer has been studied extensively. The
literature was reviewed by IARC in 2004 (International Agency for Research on Cancer,
2006) and formaldehyde was classified as a Human Carcinogen, based on an increase in
nasopharyngeal cancer (NPC) in the National Cancer Institute (NCI) cohort of >25,000
formaldehyde workers in 10 plants (Hauptmann et al., 2004). NPC was significantly
elevated in one of the 10 plants, with 6/10 NPC being diagnosed in the Wallingford, CT
plant workers, while workers at the other 9 plants had a 35% deficit in NPC. The other two
largest cohort studies did not find increases in NPC cancer (Coggon et al., 2003; Pinkerton
et al., 2004). Marsh et al., conducted an independent study of the Wallingford, CT plant
workers and confirmed the increase in NPC (Marsh et al., 2007). However, they also
showed that there was little evidence of a dosedependent relationship between NPC and
formaldehyde exposure, and that 5/6 workers had a work history of silver smithing, brass
plating and metal work, which involves acid mists and has been associated with human NPC
(Marsh et al., 2007). Thus, confounding by exposure to other chemicals could not be
excluded as the cause of elevated NPC in the Wallingford, CT plant. Four recent reviews/
meta analyses concluded that there was little support for formaldehyde causing NPC
(Bachand et al., 2010; Bosetti et al., 2008; Collins et al., 1997; Duhayon et al., 2008). In
contrast, IARC reiterated its conclusion that “Formaldehyde causes cancer of the
nasopharynx” in 2012. Clearly, there is biologic plausibility for formaldehyde causing NPC,
as it is the initial site of contact for inhalation exposures. However, the overall data for
human exposures appear to be limited at best.
Hauptmann et al., (Hauptmann et al., 2003) also examined the NCI cohort of formaldehyde
workers for associations of formaldehyde exposure with hematolymphopoietic cancers. The
association was strongest with peak exposures, but not with the more traditional cumulative
exposure dose metric. This study was considered to provide limited evidence in humans by
IARC (International Agency for Research on Cancer, 2006). In contrast, the UK cohort had
a deficit in hematolymphopoietic cancers, yet had the highest exposures of the three large
industry cohorts (Coggon et al., 2003). The NCI cohort was updated (Beane Freeman et al.,
2009) to include workers who died between 1994 and 2004. It was also noted that 1006
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deaths from the Hauptmann et al., (Hauptmann et al., 2003) study had been left out of that
paper's analyses. When these workers, plus the additional 10 years of follow-up were
analyzed, evidence for leukemia was weakened and no relationship between cumulative
formaldehyde exposure and hematolymphopoietic malignancies was found. A third study
reported an increase in myeloid leukemia in embalmers exposed to formaldehyde that was
associated with the number of years of embalming (Hauptmann et al., 2009), however, no
measurements of formaldehyde exposure were conducted as part of this study.
There have not been any reports that demonstrate if or how inhaled formaldehyde reaches
sites distant to the site of initial contact following inhalation exposure. Thus, the limited
evidence for formaldehyde causing hematolymphopoietic cancers and the biological
implausibility of the hypothesis that inhaled formaldehyde causes leukemia has raised many
questions (Committee to Review EPA's Draft IRIS Assessment of Formaldehyde and and
National Research Council, 2011).
Early Mode of Action Studies
During the 1980-1990s, extensive research was conducted on cell proliferation,
mutagenicity, and species differences in effects of formaldehyde exposure on respiratory
minute volume (Chang et al., 1983). The latter effects provide important information that
accounts for the marked species differences in carcinogenicity between rats and mice. When
mice are exposed to 15 ppm formaldehyde, they reduce their respiratory minute volume so
that they have the equivalent of a rat exposure to 6 ppm formaldehyde. Likewise, cell
proliferation was concentration- and species-dependent, with rats exposed to 15 ppm for 5
days having > 20-fold increases in cell proliferation in the nasal respiratory epithelium. Mice
also had increases in cell proliferation, but they were less pronounced. The most extensive
study on formaldehyde-induced effects on cell proliferation was the mechanistic
carcinogenesis bioassay by Monticello et al.,(Monticello et al., 1996). It determined the
number of cells in each region of the nasal respiratory epithelium and the extent of cell
proliferation in each region. As discussed above, exposure-related increases in cell
proliferation were determined at 6, 12, and 18 months of exposure (Fig. 1).
Species differences in airflow were shown using upper respiratory castings of the rat,
nonhuman primate and human (Kimbell et al., 2001b). This study demonstrated differences
in the distribution and quantity of formaldehyde exposure across species.
Careful physical chemistry-based studies of formaldehyde-induced DNA-protein cross-links
were conducted by Heck and Casanova (Casanova-Schmitz et al., 1984; Heck et al., 1990).
These demonstrated a nonlinear relationship between cross-links and airborne formaldehyde
concentration, with disproportionately greater amounts of DNA-protein cross-links (DPC)
per ppm formaldehyde at exposures of 6 ppm and greater, reflecting saturation of the
glutathione detoxication pathways. This is illustrated in Figure 2. They also found no
evidence for accumulation of DPC in multiple day exposures (Casanova et al., 1994).
However, the methods could not distinguish between loss, repair and protease degradation
of the cross-links to small peptides. Furthermore, while the methods could distinguish DPC
arising from inhaled formaldehyde when radiolabeled formaldehyde was used, the methods
could not quantify DPC arising from endogenously formed formaldehyde.
The carcinogenicity and mechanistic studies of formaldehyde have been incorporated into
detailed biologically-based models for predicting the exposure-response for use in risk
assessment (Conolly et al., 2003; Conolly et al., 2004). The data are consistent with high
concentrations of formaldehyde being causal for nasal cancer, with disproportionately lower
risks as exposures go below 2 ppm formaldehyde. A recent review of the Draft IRIS Risk
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Assessment on Formaldehyde (US Environmental Protection Agency, 2010) by the National
Academy of Sciences strongly endorsed the use of the biologically-based models for
formaldehyde's risk assessment (Committee to Review EPA's Draft IRIS Assessment of
Formaldehyde and and National Research Council, 2011).
Recent Mode of Action Studies
Studies on Endogenous vs Exogenous Formaldehyde DNA Adducts
While it has long been known that formaldehyde is formed endogenously in all living cells,
accurate measurements of its binding to DNA and proteins had never been made. Making
use of mass spectrometry as a major tool for quantifying DNA damage and repair, we
hypothesized that we could expose cells and intact animals to [13CD2]-formaldehyde, and
thereby differentiate between the DNA adducts that arose from inhaled [13CD2]-
formaldehyde and those that arose from endogenously formed formaldehyde. Lu et al., (Lu
et al., 2010b) analyzed the in vitro reactions between formaldehyde and all of the amino
acids and deoxynucleosides, and their oligomers. This study demonstrated that
formaldehyde reacted predominantly with deoxyguanosine (dG). It also readily formed
cross-links between lysine and dG, but these cross-links rapidly disintegrated, with a half-
life of minutes. In contrast, dG cross-links with cysteine were much more stable. We knew
that formaldehyde formed N2-hydroxy-methyl-dG adducts, so we exposed rats by nose-only
inhalation to 10 ppm [13CD2]-formaldehyde for 6 hr/day for 1 or 5 days (Lu et al., 2010a),
and rat tissues were analyzed for [13CD2]-N2-hydroxy-methyl-dG adducts resulting from the
exposure, as well as [12CH2]-N2-hydroxy-methyl-dG adducts that were of endogenous
origin. Since N2-hydroxy-methyl-dG adducts are not stable, they were reduced to N2-
methyl-dG adducts using cyanoborohydride. Figure 3 illustrates the approach used for these
experiments. The first study using stable isotope formaldehyde exposures provided clear
evidence that inhaled formaldehyde reached the initial site of contact, the nasal respiratory
epithelium. However, no [13CD2]-N2-methyl-dG adducts were detectable in other more
distant tissues, including lung, liver, spleen, mononuclear white blood cells or bone marrow
(Table 1). In contrast, all tissues had endogenous N2-methyl-dG adducts. Of additional
interest, endogenous N6-deoxyadenosine-hydroxy-methyl adducts were also found in all
tissues, but no [13CD2]-N6-hydroxy-methyl-dA adducts were found in any tissues. Finally,
dG-[13CD2]-dG cross-links were quantified and found to be formed at ∼10% of the
[13CD2]-N2-hydroxy-methyl-dG monoadducts. Lu et al., (Lu et al., 2010a) also showed that
these cross-links form artifactually during sample preparation, suggesting that they are not a
reliable biomarker of exposure. This study provided compelling information that inhaled
formaldehyde does not reach tissues distant to the site of initial contact, raising major
questions about the biological plausibility of hypotheses that inhaled formaldehyde causes
leukemia.
Our methods for analyzing formaldehyde DNA adducts have recently been refined by
switching from capillary liquid chromatography to a nano-UPLC system, providing a 10-
fold lower detection limit (20 amol). This improved methodology was applied in three
additional formaldehyde inhalation studies. Lu et al., (Lu et al., 2011) examined the
molecular dosimetry of rat nose-only exposures to 0, 0.7, 2.0, 6, 10, or 15 ppm [13CD2]-
formaldehyde for 6 hours. This study demonstrated striking differences in the ratio of
endogenous to exogenous N2-hydroxy-methyl dG adducts. At 0.7 ppm, there were
approximately 100 endogenous formaldehyde adducts for each exogenous formaldehyde
DNA adduct present in rat nasal DNA. Table 2 shows the abundance of each adduct type as
functions of exposure concentration. Only exposure to 15 ppm [13CD2]-formaldehyde for 6
hours induced exogenous adducts in greater numbers than the endogenous adducts that were
always present. It should be pointed out that the endogenous formaldehyde DNA adducts
were at steady-state, whereas a single 6 hour exposure does not produce steady-state
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amounts. Experiments that will establish the number of daily exposures needed to achieve
near-steady-state exogenous formaldehyde adduct concentrations are currently underway.
The same inhalation study (Lu et al., 2011) utilized additional rats exposed to a single 6
hour nose-only exposure to 10 ppm [13CD2]-formaldehyde. The additional animals were
used to estimate the half-life of the [13CD2]-N2-hydroxy-methyl-dG adducts in rat nasal
mucosa following a high concentration exposure. The study was designed to compare the
number of exogenous DNA adducts at the end of a 6 hour, 10 ppm exposure with those for
6, 12, 24, 48 and 72 hours post-exposure (n= 4-5 rats per time point). The data are shown in
Fig. 4. The loss of nearly half of the adducts in the first 6 hours post-exposure was
surprising. This rapid initial falloff was followed by a relatively constant decrease in adducts
with a T1/2 of 63 hours (R2 = 0.771). The rapid loss during the first 6 hours post-exposure is
thought to be the result of cell death, not DNA repair, whereas the subsequent decreases
over three days are believed to reflect DNA repair and/or spontaneous decomposition. The
T1/2 for the repair/loss of [13CD2]-N2-hydroxy-methyl-dG adducts will be further elucidated
in a 28 day study using exposures to 2 ppm [13CD2]-formaldehyde (6 hr/day, 7 days/week),
with post-exposure times of 0, 6, 24, 72 and 168 hours. The exposures for this additional
study have been completed, but the DNA adducts have not yet been analyzed. This study is
not expected to show the rapid loss by 6 hours post-exposure, as 2 ppm inhalation exposures
to formaldehyde have not resulted in prominent cytotoxicity or increased cell repair. The
exogenous DNA adducts will likely have approached steady-state concentrations during this
longer study, and this extended study should provide the rate of loss of the [13CD2]-N2-
hydroxy-methyl-dG adducts under conditions more akin to past human occupational
exposures.
A third inhalation study with stable isotope formaldehyde (Moeller et al., 2011) was
conducted in nonhuman primates (NHP) with the 20 amol detection limit. This study is
important because rats are obligatory nose breathers, while humans and NHP breathe both
nasally and orally. This study was conducted using whole body exposures to 1.9 or 6.1 ppm
of [13CD2]-formaldehyde, 6 hr/day for 2 consecutive days. As in the rat studies, exogenous
DNA adducts were only detected in nasal DNA. No exogenous adducts were detected in
bone marrow, where a minimum of 300 μg of DNA was analyzed, using HPLC fraction
collection of the endogenous and exogenous N2-methyl-dG adducts. The entire fraction was
then applied to the nano-UPLC-MS/MS. This provided us with the ability to detect as few as
one [13CD2]-N2-methyl-dG adduct in 10 billion dGs. No exogenous adducts were found,
despite exquisite sensitivity. This study provides additional compelling data that inhaled
formaldehyde does not reach the bone marrow of primates. In further analysis of the primate
tissues, no exogenous DNA adducts were detected in multiple regions of the brain, several
sections of the lungs, and nasopharynx. Exogenous adducts were detected in the dorsal nasal
cavity from the 6 ppm exposures with exogenous adducts at ∼ 15% of the maxilloturbinate
levels. Together, the data support the argument for formaldehyde being a nasal carcinogen
and shed additional light on the contribution of differences in nasal anatomy and breathing
patterns between species on the distribution of inhaled formaldehyde. Given that inhaled
formaldehyde was again not detectable in distant tissues, the plausibility that inhaled
formaldehyde can cause leukemia must be seriously questioned.
Epigenetic Effects of Inhaled Formaldehyde
In order to further investigate molecular mechanisms underlying formaldehyde-induced
health effects, our research team has investigated additional epigenetic changes caused by
formaldehyde exposure. Epigenetic changes are not mutations, but include altered DNA
methylation, histone methylation, and changes in microRNA (miRNA) expression. Using in
vitro exposures, we have demonstrated that formaldehyde binds to the lysine molecules in
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histone 4. Furthermore, when a histone lysine is adducted to formaldehyde, it cannot be
acetylated, and if it was acetylated, it could not bind formaldehyde (Lu et al., 2008).
Our team has investigated whether formaldehyde exposure disrupts miRNA expression
levels within cultured lung cells (Rager et al., 2010). It is important to investigate potential
effects of formaldehyde on miRNAs because they regulate gene expression by binding to
mRNA, causing 1) rapid decay of the message, (2) translational repression of the mRNA
signals, and (3) inducing cleavage of newly translated polypeptides (Filipowicz et al., 2008).
If miRNA expression is increased by formaldehyde exposure, the targeted mRNA and
proteins can be reduced. Conversely, if the miRNA has decreased expression, one expects
increased mRNA and translation of proteins. In our study, human A549 lung epithelial cells
were exposed to formaldehyde (1 ppm) using an in vitro exposure system that physically
simulates in vivo human lung exposures. Upon exposure to formaldehyde, the lung epithelial
cells showed decreased expression in 89 of 534 miRNAs that we measured using human
miRNA microarrays. All of the modulated miRNAs were down-regulated by formaldehyde
exposure. This general trend of miRNA down-regulation has been observed in rat lung cells
exposed to cigarette smoke (Izzotti et al., 2009), as well as in multiple tumor cell types,
including lung cancer, breast cancer, and leukemia (Lu et al., 2008).
More recently, we have examined the effects of formaldehyde exposures on microRNA
expression in the maxilloturbinate of Cynomolgus monkeys exposed to 2 or 6 ppm
formaldehyde. If miRNA expression is increased by formaldehyde exposure, the targeted
mRNA and proteins are reduced, while if the miRNA has decreased expression, one expects
increased mRNA and translation of proteins. In the primate study, when comparing miRNAs
in tissue from unexposed controls, we identified 3 miRNAs with altered expression in the
maxilloturbinate of monkeys exposed to 2 ppm formaldehyde and 13 miRNAs with altered
expression when exposures were to 6 ppm formaldehyde. MiRNA-125b had the greatest
increase in expression and this was confirmed with RT-PCR. We then predicted
transcriptional targets of miR-125b and used a systems biology approach to identify
associated signaling pathways. This systems-level analysis revealed that apoptosis signaling
was likely modified by formaldehyde's effect on miRNA expression. This prediction was
confirmed at the gene expression level, where all apoptosis-related targets of miR-125b,
specifically BAK1, CASP2, MAP2K7 and MCL1, were decreased in formaldehyde-exposed
samples. Of additional interest, MAP2K7 and MCL1 had previously been shown to have
altered gene expression in rat nasal tissue (Andersen et al., 2010).
We are currently examining miRNA expression in tissues from rats exposed to 2 ppm
[13CD2]-formaldehyde for 4 weeks (6 hrs/day, 7 days/wk). To date, we have identified 59
miRNAs with altered expression in the nasal epithelium, 8 miRNAs with altered expression
in mononuclear WBCs, and no miRNAs with altered expression in bone marrow. The
greatest decrease in expression occurred in miRNA-203, in the nasal tissue of both rats and
nonhuman primates. Using a systems biology approach, we predicted transcriptional targets
for miRNA-203 and found Rap1 and RaP1A, members of the ras oncogene family, to be
affected. Andersen et al., (Andersen et al., 2010) also observed altered expression in Rap1
and RAP1A in formaldehyde-exposed rat nasal epithelium. This study will also include
exposures to 2 ppm [13CD2]-formaldehyde for 1 week, as well as 1 week post-exposure after
the 4 weeks of exposure. These additional time points will allow us to determine temporal
relationships for altered miRNAs. In addition, we will examine methylation of DNA for the
same exposure groups.
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Cancer Risk Assessment of Formaldehyde
The demonstration that formaldehyde is an animal carcinogen that induced a very high
incidence of nasal cancer in rats provoked widespread concerns regarding potential human
health effects resulting from formaldehyde exposure. Quantitative risk assessment methods
were still being developed, with emphasis on linearized multistage models that utilized high
administered dose cancer incidence data collected in laboratory animal bioassays (Cohn,
1981; U.S.Environmental Protection Agency, 1984; US Consumer Product Safety
Commission, 1982). These early risk assessments did not utilize any data from the early
mode of action studies discussed above. Starr and Gibson pointed out that such assessments
needed to take into account the differences between administered dose and delivered dose,
as this distinction could make enormous differences in estimated risks (Starr and Gibson,
1985). In spite of this, most quantitative risk assessments, even to the present day, continue
to use administered doses with the linearized multistage approach to low dose human cancer
risk assessment. Using such approaches is, in essence, equivalent to stating that none of the
mode of action data inform our understanding of the potential low-dose risks for cancer
associated with formaldehyde. Ironically, just using the delivered dose formaldehyde data
developed in the early 1980s lowered the multistage maximum likelihood risk estimates by a
factor of 53 (Starr and Gibson, 1985).
Today, our knowledge regarding the mode of action of formaldehyde-induced
carcinogenesis is much greater, yet most of this new knowledge has not been applied in
assessments of formaldehyde risk (International Agency for Research on Cancer, 2012;
National Toxicology Program, 2011; US Environmental Protection Agency, 2010). The
NRC (Committee to Review EPA's Draft IRIS Assessment of Formaldehyde and and
National Research Council, 2011) review of the EPA report (US Environmental Protection
Agency, 2010) was critical of its lack of use of mode of action data, as well as its lack of use
of the biologically-based models. We now have much greater knowledge of the distribution
of endogenous and inhaled formaldehyde at the molecular level. Two such findings are of
great importance: (1) every living cell contains formaldehyde and measurable formaldehyde
N2-hydroxy-methyl-dG adducts; and (2) there is no evidence that inhaled formaldehyde
reaches sites distant to the initial site of contact. Indeed, there is strong evidence that inhaled
formaldehyde does not reach any distant tissues. Likewise, no consideration has been given
to confounding for NPC in the Wallingford, CT plant workers, even though the other 9
plants had a 35% decrement in the expected number of NPC cases.
Data regarding the molecular dose of formaldehyde reaching various tissues has recently
been employed in a new “bottom-up” risk assessment approach that places useful upper
bounds on low-dose cancer risks that do not depend upon high dose data for humans or
animals. Thus, this novel approach provides an independent “reality check” on low dose risk
estimates that are derived with models fit to high dose cancer data (Starr and Swenberg,
2012). This approach 1) is consistent with the “additivity to background” concept, 2) yields
central and upper-bound risk estimates that are linear at all doses, and 3) only requires
information regarding background risk and background exposures to be implemented. Using
the molecular data for endogenous and exogenous DNA adducts from the primate study of
Moeller et al., (Moeller et al., 2011) and the detection limit of 20 × 10-18 mol of N2-
hydroxy-methyl-dG, central and lower 95% confidence bound estimates of steady-state
exogenous adducts expected to arise in nasal mucosa and bone marrow from continuous 24
hrs/day, 7 days/week exposure to 2 ppm formaldehyde were developed. Background human
risk estimates for nasopharyngeal cancer and leukemia were taken from the 2010 EPA draft,
(US Environmental Protection Agency, 2010)and SEER Cancer Statistics Review,
1975-2007 (Altekruse et al., 2010), respectively. The upper bound estimate of NPC risk
obtained with the “bottom-up” approach was nearly 29-fold lower than EPA's plausible
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upper bound estimate derived from high dose epidemiology data. For the risk of leukemia,
the “bottom-up” upper bound risk estimate was more than 14,000-fold lower than EPA's
corresponding estimate, again as it was derived from high dose epidemiology data. These
results strongly support a conclusion that the much larger risk estimates derived by the EPA
(US Environmental Protection Agency, 2010), are overly conservative. It is thus imperative
that high quality mode of action data be brought into the risk assessment process and that the
traditional risk assessment assumptions that lack such strong scientific bases are tested
rigorously.
When USEPA developed lifetime human nasal cancer risk estimates from tumor data for
rats, the Agency made adjustments for human-rat differences in nasal anatomy, breathing
rates, and exposure duration (US Environmental Protection Agency, 2010). Results from
Computational Fluid Dynamics (CFD) modeling simulations conducted by Kimbell et al.
(Kimbell et al., 2001a; Kimbell et al., 2001b) were utilized to compute the average flux of
formaldehyde into rat nasal tissues (excluding those from the olfactory region) that results
from exposure, at resting breathing rates, to a given airborne formaldehyde concentration. A
similar calculation was undertaken for human nasal tissues (including those from the
olfactory region) exposed to the same airborne formaldehyde concentration at breathing
rates corresponding to equal durations (8 hours) of resting, light, and moderate activity
levels.
The rat-to-human ratio of these average flux rates under the specified conditions was
determined to be 0.46 (US Environmental Protection Agency, 2010). This implies that
approximately twice (1/0.46) the amount of formaldehyde is expected to be deposited in the
nasal tissues of humans as would be deposited in the non-olfactory nasal tissues of rats when
both species are exposed to the same airborne formaldehyde concentration. Alternatively, it
implies that the “human equivalent” exposure concentration that corresponds to a given rat
exposure concentration is approximately one-half (a factor of 0.46) as large. Thus, at least
according to this Agency computation, humans are expected to be about twice as sensitive as
rats to the carcinogenic effects of airborne formaldehyde in nasal tissues.
This rat-to-human ratio can also be estimated from rat-to-monkey using molecular dosimetry
data for DPC from Heck et al. (Heck et al., 1990) and exogenous DNA adducts derived from
Lu et al., (Lu et al., 2011) and Moeller et al., (Moeller et al., 2011), since the anatomy and
breathing patterns of humans and monkeys are similar (Kimbell et al., 2001b). Monitoring
DPC formation in rats and primates showed that at 2 and 6 ppm the ratio of rat-to-primate
DPC formation was approximately 6 at both concentrations. Thus, the molecular dose of
formaldehyde DNA damage suggests that the data driven ratio for rats-to-humans is also
likely to be ∼6, rather than 0.46. The more recent primate studies investigating exogenous
DNA adduct formation can be compared in a similar manner by dividing the exogenous
adducts by the length of exposure (6 hours for rats and 12 hours for primates) with the ratio
of rat-to-primate formation being ∼1.5 and 5.1 at 2 and 6 ppm, respectively. The ratio of
formation of exogenous DPCs and adducts in the nasal tissues between the two species is
very similar at the 6 ppm exposure concentration, while it is less similar at 2 ppm. While
differences exist between the two biomarkers of exposure (DPC and adducts), it is
remarkable that similar results were obtained using completely different methodologies
nearly 20 years later. Since DNA damage is considered a key event in formaldehyde's MOA,
these data provide an important check on the accuracy of the EPA estimated effects of
inhalation exposure for humans.
In summary, over 30 years of intense research on formaldehyde has provided a path forward
for improving the way we evaluate carcinogens, examine dose-response relationships, and
conduct critical mode of action studies to better understand the processes that drive the
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biology of carcinogenesis in animals and humans. The results of such efforts should play
major roles in science-based risk assessments that will more accurately predict human risks
for inhaled exposures to humans and protect the public health.
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Incidence of squamous cell carcinoma of the nasal passages and cell proliferation in rats
exposed to formaldehyde. □ shows tumor incidence (%) from the 24 month study versus
formaldehyde concentration (ppm) (Kerns et al., 1983). ○ shows tumor incidence from the
24-month study (Monticello et al., 1996). ▲ shows cell proliferation (mean unit length
labeling index) from the 6 month study as fold increase over control (Monticello et al.,
1990). ◆ shows cell proliferation (mean unit length labeling index) from the 12 month study
as fold increase over control (Monticello et al., 1990). ● shows cell proliferation (mean unit
length labeling index) as fold increase over control (Monticello, Morgan, and Hurtt, 1990).
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Nonlinear formation of formaldehyde DNA-protein cross-links following inhalation
exposure of rats and normalization per ppm. Adapted from Casanova et al.,1984.
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Analytical approach for the quantitation of endogenous and exogenous formaldehyde DNA
adducts. The left panel outlines the methodology for the determination of the DNA adducts.
The upper right panel shows the formation of the endogenous (upper route) and exogenous
(lower route) N2-OHMedG adducts. The lower right panel shows the representative LC-MS/
MS chromatograms of endogenous, exogenous and isotope-labeled internal standard.
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The half-life of [13CD2]-N2-OHMedG adducts in rat nasal mucosa. Data was transformed
using natural log and a linear regression was accomplished using the last 5 time points.
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Table 2
Formaldehyde-induced N2-OHMe-dG adducts in the nasal epithelium of rats exposed to [13CD2]-
formaldehyde for 6 hr.
exposure (ppm) endogenous dG adduct (adducts/107 dG) exogenous dG adducts (adducts/107 dG)
0.7±0.2 3.62±1.33a 0.039±0.019
2.0±0.1 6.09 ±3.03b 0.19±0.08
5.8± 0.5 5.51 ±1.06c 1.04 ±0.24
9.1±2.2 3.41 ±0.46 2.03 ±0.43
15.2±2.1 4.24 ±0.92 11.15±3.01
Adapted from Lu et al. (2011).
a
Four to six rat samples were combined for each mass spectrometry measurement; n = 3.
b
Two rat samples were combined for each mass spectrometry measurement; n = 4.
c
Rat samples were not combined for 5.8, 9.1, and 15 ppm groups; typically n = 5.
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